HomeAI · summaries
Storia in 6 fonti
Decades-long dream powering Chemist Warehouse’s risky tilt at Boots
Chief executive Mario Verrocchi has admired the British pharmacy chain for more than four decades. But any deal to buy the UK group would be laden with risks.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
afr.com
Chemist Warehouse owner in talks over $14b Boots sale: FT
ASX-listed Sigma Healthcare is looking at Boots alongside other bidders including Canada’s wealthy Weston family, the report said.
- ·
Chemist Warehouse’s owner Sigma bankers up to weigh bid for UK’s Boots
It would see Chemist Warehouse’s owner lock horns with Canada’s wealthy Weston family, which owns the grocery chain Loblaws and the pharmacy chain Shoppers Drug Mart.
- ·
theage.com.au
Chemist Warehouse owner eyes $14 billion deal for UK giant
The Australian pharmacy giant now has its sights set on the UK pharmacy chain Boots.
- ·
smh.com.au
Chemist Warehouse owner eyes $14 billion deal for 177-year-old UK giant
The Australian pharmacy giant now has its sights set on the UK pharmacy chain Boots.
- ·
Decades-long dream powering Chemist Warehouse’s risky tilt at Boots
Chief executive Mario Verrocchi has admired the British pharmacy chain for more than four decades. But any deal to buy the UK group would be laden with risks.
- ·
news.com.au
Chemist Warehouse’s huge UK move
Australian pharmacy group Chemist Warehouse has entered talks to buy UK health and beauty chain Boots for a reported $14bn.
- ·
independent.co.uk
Australia’s Sigma confirms talks over Boots takeover
It followed reports the Weston family is also holding discussions over a possible £7.5 billion deal.
- ·
dailymail.com
UK pharmacy chain Boots could be swallowed up by Chemist Warehouse
Sigma Healthcare, the owner of Chemist Warehouse, confirmed it is trying to buy UK pharmacy giant Boots.
- ·
Chemist Warehouse gets the crocodile roll treatment
The pharmacy giant’s hunt for a global prize could lead it to rapidly lose control of the situation and become trapped in the notorious graveyard of failed offshore M&A.